New mechanism that predicts a competitive advantage to SARS-CoV-2 virus carrying the D614G spike mutation

Research by two U.S.-based antibody discovery companies shows a rise and dominance of a mutant SARS-CoV-2 virus and identifies a new mechanism predicting a competitive advantage of the mutation. The mutation is predicted to induce a structural change in the spike protein of the virus that would enhance virus entry. The study, conducted by Antibody Solutions and Single Cell Technology (SCT), is available on Preprints.org…

Single Cell Technology and AB Biosciences announce collaboration

Single Cell Technology, Inc. (SCT) and AB Biosciences (ABB) today announced a collaboration to identify therapeutic antibodies. SCT will utilize its patented platform to massively screen plasma cells, measure the kinetics of secreted antibodies, and sequence the…